Weake, VM,Workman, JL.Inducible gene expression: diverse regulatory mechanisms.Nat Rev Genet2010,11:426–437.
Risch, A,Plass, C.Lung cancer epigenetics and genetics.Int J Cancer2008,123:1–7.
Wu, X,Piper‐Hunter, MG,Crawford, M,Nuovo, GJ,Marsh, CB,Otterson, GA,Nana‐Sinkam, SP.MicroRNAs in the pathogenesis of lung cancer.J Thorac Oncol2009,4:1028–1034. doi: 10.1097/JTO.0b013e3181a99c77.
American Cancer Society. Cancer Facts and Figures. Available at:www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer‐facts‐and‐figures‐2010.
Jemal, A,Siegel, R,Ward, E,Hao, Y,Xu, J,Murray, T,Thun, MJ.Cancer statistics, 2008.CA Cancer J Clin2008,58:71–96.
West, CML,McKay, MJ,Hölscher, T,Baumann, M,Stratford, IJ,Bristow, RG,Iwakawa, M,Imai, T,Zingde, SM,Anscher, MS, et al.Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.Int J Radiat Oncol Biol Phys2005,62:1264–1273.
Herbst, RS,Heymach, JV,Lippman, SM.Lung cancer.N Engl J Med2008,359:1367–1380.
Spira, A,Ettinger, DS.Multidisciplinary management of lung cancer.N Engl J Med2004,350:379–392.
Perez, CA.Principles and Practice of Radiation Oncology.4th ed.Philadelphia, PA: Lippincott Williams %26 Wilkins;2004.
Bradley, JD,El Naqa, I,Drzymala, RE,Trovo, M,Jones, G,Denning, MD.Stereotactic body radiation therapy for early‐stage non‐small‐cell lung cancer: the pattern of failure is distant.Int J Radiat Oncol Biol Phys2010,77:1146–1150.
Hall, EJ,Giaccia, AJ.Radiobiology for the Radiologist6th ed.Philadelphia, PA: Lippincott Williams %26 Wilkins;2006.
Marples, B,Longhurst, D,Eastham, AM,West, CM.The ratio of initial/residual DNA damage predicts intrinsic radiosensitivity in seven cervix carcinoma cell lines.Br J Cancer1998,77:1108–1114.
Lehnert, S.Biomolecular Action Of Ionizing RadiationNew York, NY: Taylor %26 Francis;2008.
Steel, GG.Basic Clinical Radiobiology3rd ed. Arnold; Oxford University Press:London New York;2002.
Kirkpatrick, JP,Marks, LB.Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data.Int J Radiat Oncol Biol Phys2004,58:641–654.
Choi, N,Baumann, M,Flentjie, M,Kellokumpu‐Lehtinen, P,Senan, S,Zamboglou, N,Kosmidis, P.Predictive factors in radiotherapy for non‐small cell lung cancer: present status.Lung Cancer2001,31:43–56.
El Naqa, I,Deasy, JO,Mu, Y,Huang, E,Hope, AJ,Lindsay, PE,Apte, A,Alaly, J,Bradley, JD.Datamining approaches for modeling tumor control probability.Acta Oncol2010,49:1363–1373.
Su, D,Ma, S,Liu, P,Jiang, Z,Lv, W,Zhang, Y,Deng, Q,Smith, S,Yu, H.Genetic polymorphisms and treatment response in advanced non‐small cell lung cancer.Lung Cancer2007,56:281–288.
Yoon, SM,Hong, YC,Park, HJ,Lee, JE,Kim, SY,Kim, JH,Lee, SW,Park, SY,Lee, JS,Choi, EK.The polymorphism and haplotypes of XRCC1 and survival of non‐small‐cell lung cancer after radiotherapy.Int J Radiat Oncol Biol Phys2005,63:885–891.
Brock, MV,Hooker, CM,Ota‐Machida, E,Han, Y,Guo, M,Ames, S,Glöckner, S,Piantadosi, S,Gabrielson, E,Pridham, G, et al.DNA methylation markers and early recurrence in stage I lung cancer.N Engl J Med2008,358:1118–1128.
Wang, X,El Naqa, IM.Prediction of both conserved and nonconserved microRNA targets in animals.Bioinformatics2008,24:325–332.
Yu, SL,Chen, HY,Chang, GC,Chen, CY,Chen, HW,Singh, S,Cheng, CL,Yu, CJ,Lee, YC,Chen, HS, et al.MicroRNA signature predicts survival and relapse in lung cancer.Cancer Cell2008,13:48–57.
Le, Q‐T,Chen, E,Salim, A,Cao, H,Kong, CS,Whyte, R,Donington, J,Cannon, W,Wakelee, H,Tibshirani, R, et al.An evaluation of tumor oxygenation and gene expression in patients with early stage non‐small cell lung cancers.Clin Cancer Res2006,12:1507–1514.
Rübe, CE,Palm, J,Erren, M,Fleckenstein, J,König, J,Remberger, K.Cytokine plasma levels: reliable predictors for radiation pneumonitis?PLoS ONE2008,3:e2898.
Oh, JH,Craft, J,Al Lozi, R,Vaidya, M,Meng, Y,Deasy, JO,Bradley, JD,El Naqa, I.A Bayesian network approach for modeling local failure in lung cancer.Phys Med Biol2011,56:1635–1651.
Akimoto, T,Hunter, NR,Buchmiller, L,Mason, K,Ang, KK,Milas, L.Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.Clin Cancer Res1999,5:2884–2890.
Sartor, CI.Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors.Nat Clin Pract Oncol2004,1:80–87.
Das, AK,Chen, BP,Story, MD,Sato, M,Minna, JD,Chen, DJ,Nirodi, CS.Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR‐mediated radioprotection in non‐small cell lung carcinoma.Cancer Res2007,67:5267–5274.
Mayo, LD,Donner, DB.A phosphatidylinositol 3‐kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.Proc Natl Acad Sci U S A2001,98:11598–11603.
Langendijk, H,Thunnissen, E,Arends, JW,de Jong, J,ten Velde, G,Lamers, R,Guinee, D,Holden, J,Wouters, M.Cell proliferation and apoptosis in stage III inoperable non‐small cell lung carcinoma treated by radiotherapy.Radiother Oncol2000,56:197–207.
Schuurbiers, OC,Kaanders, JH,van der Heijden, HF,Dekhuijzen, RP,Oyen, WJ,Bussink, J.The PI3‐K/AKT‐pathway and radiation resistance mechanisms in non‐small cell lung cancer.J Thorac Oncol2009,4:761–767.
Hirami, Y,Aoe, M,Tsukuda, K,Hara, F,Otani, Y,Koshimune, R,Hanabata, T,Nagahiro, I,Sano, Y,Date, H,Shimizu, N.Relation of epidermal growth factor receptor, phosphorylated‐Akt, and hypoxia‐inducible factor‐1[alpha] in non‐small cell lung cancers.Cancer Lett2004,214:157–164.
Dent, P,Yacoub, A,Contessa, J,Caron, R,Amorino, G,Valerie, K,Hagan, MP,Grant, S,Schmidt‐Ullrich, R.Stress and radiation‐induced activation of multiple intracellular signaling pathways.Radiat Res2003,159:283–300.
Citrin, D,Menard, C,Camphausen, K.Combining radiotherapy and angiogenesis inhibitors: clinical trial design.Int J Radiat Oncol Biol Phys2006,64:15–25.